Lilly details plans for $850m investment in U.S. operations

Eli Lilly (NYSE:LLY) said today that it plans to invest $850 million in its U.S. operations in 2017. The company presented details of its plans at the Lilly Technology Center in Indianapolis, joined by federal, state and local government officials.

Lilly said it will invest in an $85 million expansion of its Trulicity device assembly operations as a part of its 5-year plan to expand manufacturing operations in the U.S. The company also officially dedicated a $140 million insulin cartridge production facility today.

The move to invest in manufacturing in the U.S. comes after President Donald Trump repeatedly urged drug- and device-makers to bring their production facilities stateside.

Get the full story at our sister site, Drug Delivery Business News.

The post Lilly details plans for $850m investment in U.S. operations appeared first on MassDevice.

from MassDevice http://ift.tt/2nM8ezH